US 11,666,531 B2
Delivery system
Thomas Hnat, San Diego, CA (US)
Assigned to SMARTECH TOPICAL, INC., San Diego, CA (US)
Appl. No. 16/87,989
Filed by SMARTECH TOPICAL, INC., San Diego, CA (US)
PCT Filed Mar. 31, 2017, PCT No. PCT/US2017/025373
§ 371(c)(1), (2) Date Sep. 24, 2018,
PCT Pub. No. WO2017/173269, PCT Pub. Date Oct. 5, 2017.
Claims priority of provisional application 62/316,064, filed on Mar. 31, 2016.
Prior Publication US 2019/0046438 A1, Feb. 14, 2019
Int. Cl. A61K 9/06 (2006.01); A61K 9/00 (2006.01); A61K 47/14 (2017.01); A61K 47/44 (2017.01); A61K 31/522 (2006.01); A61K 31/216 (2006.01); A61K 31/352 (2006.01); A61K 31/192 (2006.01); A61K 31/196 (2006.01); A61K 31/167 (2006.01); A61K 31/714 (2006.01); A61K 31/385 (2006.01); A61K 31/245 (2006.01); A61K 47/10 (2017.01); A61K 45/06 (2006.01)
CPC A61K 9/06 (2013.01) [A61K 9/0014 (2013.01); A61K 31/167 (2013.01); A61K 31/192 (2013.01); A61K 31/196 (2013.01); A61K 31/216 (2013.01); A61K 31/245 (2013.01); A61K 31/352 (2013.01); A61K 31/385 (2013.01); A61K 31/522 (2013.01); A61K 31/714 (2013.01); A61K 45/06 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61K 47/44 (2013.01)] 6 Claims
 
1. A formulation for human or veterinary use, said formulation comprising:
(a) diclofenac;
(b) oleic acid;
(c) at least one organic solvent selected from the group consisting of dimethyl isosorbide, dimethyl formamide, ethanol, ethyl acetate, 1,2-propanediol, 1,3-propanediol, and glycerin;
(d) dimethylsulfoxide; and
(e) hydroxypropyl cellulose;
wherein:
said formulation is a non-aqueous transparent gel.